Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice

Arginase-2 Mediates Diabetic Renal Injury

(2011) Sidney M. Morris et al.   DIABETES

Endothelial Factors and Diabetic Nephropathy

(2011) J. Karalliedde et al.   DIABETES CARE

Addition of Angiotensin II Type 1 Receptor Blocker to CCR2 Antagonist Markedly Attenuates Crescentic Glomerulonephritis

(2011) Maki Urushihara et al.   HYPERTENSION

An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes

(2011) Sufyan G. Sayyed et al.   KIDNEY INTERNATIONAL

Pathogenesis of diabetic nephropathy

(2011) Zemin Cao et al.   Journal of Diabetes Investigation

Targeting the MCP-1/CCR2 System in Diabetic Kidney Disease

(2010) Sara Giunti et al.   Current Vascular Pharmacology

CCR2 antagonism improves insulin resistance, lipid metabolism, and diabetic nephropathy in type 2 diabetic mice

(2010) Young Sun Kang et al.   KIDNEY INTERNATIONAL

The Role of chemokines and chemokine receptors in diabetic nephropathy

(2007) Christiane Ruster   Frontiers in Bioscience-Landmark